Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study
Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are s...
Gespeichert in:
Veröffentlicht in: | Journal of proteome research 2022-03, Vol.21 (3), p.822-832 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 832 |
---|---|
container_issue | 3 |
container_start_page | 822 |
container_title | Journal of proteome research |
container_volume | 21 |
creator | Jiang, Cheng-Hong Lin, Peng-Fei Chen, Fa-Chun Chen, Jia-Yao Xie, Wen-Jun Li, Ming Hu, Xiao-Jie Chen, Wen-Lian Cheng, Yu Lin, Xiao-xi |
description | Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all >0.943. Phenylacetic acid had potential to predict infants with large IH (diameter >2 cm) from those with small IH (diameter |
doi_str_mv | 10.1021/acs.jproteome.1c00430 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2555973063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555973063</sourcerecordid><originalsourceid>FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</originalsourceid><addsrcrecordid>eNqFkEFP4zAQhS0EWqC7PwHkI5cWTxyThBtUsCAVsVqWczSxJ8jgxMVOKnHgv69LC1dOY43fezPzMXYEYgYig1PUcfa8DH4g39EMtBC5FDvsAJRUU1mJYvfzXVZynx3G-CwEqELIH2xf5hIqEOUBe7-jARvvrOZ_gm-ts_0T_0srQkcmtchYPVjf80vrOwwvFCJvfeC3fYv9YB3xG-qwf1r_ctvzx65JGRodn_tg-KXz3vAHCnjOL9YT4pJS3or4wzCat59sr0UX6de2Ttjj9dW_-c10cf_7dn6xmKJUMExzBQBYwJnRbSkykipvpBaIjcS8VGAUaqUp12VTtIBNW5lM56JSRpQ5NZmcsJNNbgL2OlIc6s5GTc5hT36MdaaUqgopzmSSqo1Up2VjoLZeBpsuf6tB1GvydSJff5Gvt-ST73g7Ymw6Ml-uT9RJABvBh9-PoU8XfxP6H9EhlcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555973063</pqid></control><display><type>article</type><title>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</title><source>ACS Publications</source><creator>Jiang, Cheng-Hong ; Lin, Peng-Fei ; Chen, Fa-Chun ; Chen, Jia-Yao ; Xie, Wen-Jun ; Li, Ming ; Hu, Xiao-Jie ; Chen, Wen-Lian ; Cheng, Yu ; Lin, Xiao-xi</creator><creatorcontrib>Jiang, Cheng-Hong ; Lin, Peng-Fei ; Chen, Fa-Chun ; Chen, Jia-Yao ; Xie, Wen-Jun ; Li, Ming ; Hu, Xiao-Jie ; Chen, Wen-Lian ; Cheng, Yu ; Lin, Xiao-xi</creatorcontrib><description>Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all >0.943. Phenylacetic acid had potential to predict infants with large IH (diameter >2 cm) from those with small IH (diameter <2 cm), with an AUC of 0.756. The novel biomarkers in noninvasive UCB sera for predicting IH before its emergence might lead to a revolutionary clinical utility.</description><identifier>ISSN: 1535-3893</identifier><identifier>EISSN: 1535-3907</identifier><identifier>DOI: 10.1021/acs.jproteome.1c00430</identifier><identifier>PMID: 34319108</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of proteome research, 2022-03, Vol.21 (3), p.822-832</ispartof><rights>2021 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</citedby><cites>FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</cites><orcidid>0000-0003-3069-9046 ; 0000-0003-3388-5485</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00430$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jproteome.1c00430$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34319108$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiang, Cheng-Hong</creatorcontrib><creatorcontrib>Lin, Peng-Fei</creatorcontrib><creatorcontrib>Chen, Fa-Chun</creatorcontrib><creatorcontrib>Chen, Jia-Yao</creatorcontrib><creatorcontrib>Xie, Wen-Jun</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><creatorcontrib>Hu, Xiao-Jie</creatorcontrib><creatorcontrib>Chen, Wen-Lian</creatorcontrib><creatorcontrib>Cheng, Yu</creatorcontrib><creatorcontrib>Lin, Xiao-xi</creatorcontrib><title>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</title><title>Journal of proteome research</title><addtitle>J. Proteome Res</addtitle><description>Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all >0.943. Phenylacetic acid had potential to predict infants with large IH (diameter >2 cm) from those with small IH (diameter <2 cm), with an AUC of 0.756. The novel biomarkers in noninvasive UCB sera for predicting IH before its emergence might lead to a revolutionary clinical utility.</description><issn>1535-3893</issn><issn>1535-3907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkEFP4zAQhS0EWqC7PwHkI5cWTxyThBtUsCAVsVqWczSxJ8jgxMVOKnHgv69LC1dOY43fezPzMXYEYgYig1PUcfa8DH4g39EMtBC5FDvsAJRUU1mJYvfzXVZynx3G-CwEqELIH2xf5hIqEOUBe7-jARvvrOZ_gm-ts_0T_0srQkcmtchYPVjf80vrOwwvFCJvfeC3fYv9YB3xG-qwf1r_ctvzx65JGRodn_tg-KXz3vAHCnjOL9YT4pJS3or4wzCat59sr0UX6de2Ttjj9dW_-c10cf_7dn6xmKJUMExzBQBYwJnRbSkykipvpBaIjcS8VGAUaqUp12VTtIBNW5lM56JSRpQ5NZmcsJNNbgL2OlIc6s5GTc5hT36MdaaUqgopzmSSqo1Up2VjoLZeBpsuf6tB1GvydSJff5Gvt-ST73g7Ymw6Ml-uT9RJABvBh9-PoU8XfxP6H9EhlcA</recordid><startdate>20220304</startdate><enddate>20220304</enddate><creator>Jiang, Cheng-Hong</creator><creator>Lin, Peng-Fei</creator><creator>Chen, Fa-Chun</creator><creator>Chen, Jia-Yao</creator><creator>Xie, Wen-Jun</creator><creator>Li, Ming</creator><creator>Hu, Xiao-Jie</creator><creator>Chen, Wen-Lian</creator><creator>Cheng, Yu</creator><creator>Lin, Xiao-xi</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3069-9046</orcidid><orcidid>https://orcid.org/0000-0003-3388-5485</orcidid></search><sort><creationdate>20220304</creationdate><title>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</title><author>Jiang, Cheng-Hong ; Lin, Peng-Fei ; Chen, Fa-Chun ; Chen, Jia-Yao ; Xie, Wen-Jun ; Li, Ming ; Hu, Xiao-Jie ; Chen, Wen-Lian ; Cheng, Yu ; Lin, Xiao-xi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a351t-45111a716dcf802e354b3c0aab3a4851d5ac5ce4c8b7f1abf9d2c4095d084eb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Cheng-Hong</creatorcontrib><creatorcontrib>Lin, Peng-Fei</creatorcontrib><creatorcontrib>Chen, Fa-Chun</creatorcontrib><creatorcontrib>Chen, Jia-Yao</creatorcontrib><creatorcontrib>Xie, Wen-Jun</creatorcontrib><creatorcontrib>Li, Ming</creatorcontrib><creatorcontrib>Hu, Xiao-Jie</creatorcontrib><creatorcontrib>Chen, Wen-Lian</creatorcontrib><creatorcontrib>Cheng, Yu</creatorcontrib><creatorcontrib>Lin, Xiao-xi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of proteome research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Cheng-Hong</au><au>Lin, Peng-Fei</au><au>Chen, Fa-Chun</au><au>Chen, Jia-Yao</au><au>Xie, Wen-Jun</au><au>Li, Ming</au><au>Hu, Xiao-Jie</au><au>Chen, Wen-Lian</au><au>Cheng, Yu</au><au>Lin, Xiao-xi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study</atitle><jtitle>Journal of proteome research</jtitle><addtitle>J. Proteome Res</addtitle><date>2022-03-04</date><risdate>2022</risdate><volume>21</volume><issue>3</issue><spage>822</spage><epage>832</epage><pages>822-832</pages><issn>1535-3893</issn><eissn>1535-3907</eissn><abstract>Infantile hemangioma (IH), the most common benign tumor in infancy, mostly arises and has rapid growth before 3 months of age. Because irreversible skin changes occur in the early proliferative stage, early medical treatment is essential to reduce the permanent sequelae caused by IH. Yet there are still no early screening biomarkers for IH before its visible emergence. This study aimed to explore prediction biomarkers using noninvasive umbilical cord blood (UCB). A prospective study of the metabolic profiling approach was performed on UCB sera from 28 infants with IH and 132 matched healthy controls from a UCB population comprising over 1500 infants (PeptideAtlas: PASS01675) using liquid chromatography–mass spectrometry. The metabolic profiling results exhibited the characteristic metabolic aberrance of IH. Machine learning suggested a panel of biomarkers to predict the occurrence of IH, with the area under curve (AUC) values in the receiver operating characteristic analysis all >0.943. Phenylacetic acid had potential to predict infants with large IH (diameter >2 cm) from those with small IH (diameter <2 cm), with an AUC of 0.756. The novel biomarkers in noninvasive UCB sera for predicting IH before its emergence might lead to a revolutionary clinical utility.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>34319108</pmid><doi>10.1021/acs.jproteome.1c00430</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-3069-9046</orcidid><orcidid>https://orcid.org/0000-0003-3388-5485</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1535-3893 |
ispartof | Journal of proteome research, 2022-03, Vol.21 (3), p.822-832 |
issn | 1535-3893 1535-3907 |
language | eng |
recordid | cdi_proquest_miscellaneous_2555973063 |
source | ACS Publications |
title | Metabolic Profiling Revealed Prediction Biomarkers for Infantile Hemangioma in Umbilical Cord Blood Sera: A Prospective Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A04%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20Profiling%20Revealed%20Prediction%20Biomarkers%20for%20Infantile%20Hemangioma%20in%20Umbilical%20Cord%20Blood%20Sera:%20A%20Prospective%20Study&rft.jtitle=Journal%20of%20proteome%20research&rft.au=Jiang,%20Cheng-Hong&rft.date=2022-03-04&rft.volume=21&rft.issue=3&rft.spage=822&rft.epage=832&rft.pages=822-832&rft.issn=1535-3893&rft.eissn=1535-3907&rft_id=info:doi/10.1021/acs.jproteome.1c00430&rft_dat=%3Cproquest_cross%3E2555973063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555973063&rft_id=info:pmid/34319108&rfr_iscdi=true |